Cargando…

Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach

PURPOSE: Targeted therapies are effective therapeutic approaches in advanced stages of NSCLC and require precise molecular profiling to identify oncogenic drivers. Differential diagnosis on a molecular level contributes to clinical decision making. Liquid biopsy (LB) use has demonstrated its potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Englmeier, Fabienne, Bleckmann, Annalen, Brückl, Wolfgang, Griesinger, Frank, Fleitz, Annette, Nagels, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020305/ https://www.ncbi.nlm.nih.gov/pubmed/35532791 http://dx.doi.org/10.1007/s00432-022-04034-w

Ejemplares similares

Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors
por: Irmer, Barnabas, et al.
Publicado: (2023)

Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023)

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)
por: Faehling, Martin, et al.
Publicado: (2022)

Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy
por: Fu, Yulong, et al.
Publicado: (2021)

Ror2 Signaling and Its Relevance in Breast Cancer Progression
por: Bayerlová, Michaela, et al.
Publicado: (2017)

Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy
por: Fu, Yulong, et al.
Publicado: (2023)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
por: Saarenheimo, Jatta, et al.
Publicado: (2019)

Microvesicles in Cancer: Small Size, Large Potential
por: Menck, Kerstin, et al.
Publicado: (2020)

Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study
por: Shen, Fangfang, et al.
Publicado: (2022)

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
por: Bertoli, Elisa, et al.
Publicado: (2023)

Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid
por: Zhai, Jinfang, et al.
Publicado: (2021)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022)

Application progress of liquid biopsy in gastric cancer
por: Ma, Xiaoting, et al.
Publicado: (2022)

Case report: Liquid biopsy, the sooner the better?
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
por: Sama, Srikar, et al.
Publicado: (2022)

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
por: Cucchiara, Federico, et al.
Publicado: (2020)

Clinical Application of Liquid Biopsy in Non-Hodgkin Lymphoma
por: Lv, Liwei, et al.
Publicado: (2021)

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022)

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
por: Freitas, Cláudia, et al.
Publicado: (2021)

Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy
por: Yan, Tian-Bao, et al.
Publicado: (2021)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

Editorial: The impact of liquid biopsies in the management of liver cancer
por: Labgaa, Ismail
Publicado: (2022)

Liquid biopsy in hematological malignancies: current and future applications
por: Talotta, Donatella, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
por: Papadopoulou, Eirini, et al.
Publicado: (2019)

Liquid biopsy in NSCLC: a new challenge in radiation therapy
por: Perillo, Annarita, et al.
Publicado: (2021)

Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers
por: Fischer, Laura E., et al.
Publicado: (2022)

Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets
por: Artmann, Stephan, et al.
Publicado: (2012)

1164P Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)
por: Sebastian, M., et al.
Publicado: (2022)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Liquid Biopsy to Detect DNA/RNA Based Markers of Small DNA Oncogenic Viruses for Prostate Cancer Diagnosis, Prognosis, and Prediction
por: Provenzano, Maurizio, et al.
Publicado: (2020)

Comparative study on gene set and pathway topology-based enrichment methods
por: Bayerlová, Michaela, et al.
Publicado: (2015)

New methodology of TMB assessment from tissue and liquid biopsy in NSCLC
por: Křížová, Ľudmila, et al.
Publicado: (2022)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018)

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cqa26lv3kjma1uf9bbrh6go12p